Acute respiratory distress syndrome induced by rifampicin with high levels of neutrophil and eosinophil products in bronchoalveolar lavage fluid

被引：10
作者：
Ashitani, J
Yanagi, S
Arimura, Y
Sano, A
Mukae, H
机构：
[1] Miyazaki Med Coll, Dept Internal Med 3, Miyazaki 8891692, Japan
[2] Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 852, Japan
来源：
RESPIRATION | 2003年 / 70卷 / 05期
关键词：
ARDS; rifampicin; pulmonary tuberculosis; BAL; eosinophil;
D O I：
10.1159/000074216
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
We reported a case with acute respiratory distress syndrome (ARDS) caused by rifampicin during therapy for pulmonary tuberculosis. A high level of eosinophil cationic protein in bronchoalveolar lavage fluid (BALF) was detected as well as interleukin-8 and neutrophil elastase. Based on these results together with the positive result of the drug lymphocyte-stimulating test, we concluded that rifampicin was the causative drug leading to ARDS. Corticosteroid therapy resulted in clinical improvement and resolution of the pulmonary infiltrates on the chest radiograph without the recurrence of pulmonary tuberculosis. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码：541 / 543
页数：3
相关论文
共 50 条
[21]   Apremilast ameliorates acute respiratory distress syndrome by inhibiting neutrophil-induced oxidative stress [J].
Tsai, Yung-Fong ;
Chen, Chun-Yu ;
Yang, Shun-Chin ;
Syu, Yu-Ting ;
Hwang, Tsong-Long .
BIOMEDICAL JOURNAL, 2023, 46 (04)
[22]   The counter-intuitive role of the neutrophil in the acute respiratory distress syndrome [J].
Vassallo, Arlette ;
Wood, Alex J. ;
Subburayalu, Julien ;
Summers, Charlotte ;
Chilvers, Edwin R. .
BRITISH MEDICAL BULLETIN, 2019, 131 (01) :43-55
[23]   Blastomycosis-Induced Acute Respiratory Distress Syndrome [J].
Ajmal, Maleeha ;
Lodhi, Fahad Aftab Khan ;
Nawaz, Gul ;
Basharat, Ahmad ;
Aslam, Afifa .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
[24]   Elevated CXCL-8 expression in bronchoalveolar lavage correlates with disease severity in patients with acute respiratory distress syndrome resulting from tuberculosis [J].
Seyed Mohamad Reza Hashemian ;
Esmaeil Mortaz ;
Payam Tabarsi ;
Hamidreza Jamaati ;
Zohreh Maghsoomi ;
Adnan Khosravi ;
Johan Garssen ;
Mohamad Reza Masjedi ;
Ali Akbar Velayati ;
Gert Folkerts ;
Peter J Barnes ;
Ian M Adcock .
Journal of Inflammation, 11
[25]   Elevated CXCL-8 expression in bronchoalveolar lavage correlates with disease severity in patients with acute respiratory distress syndrome resulting from tuberculosis [J].
Hashemian, Seyed Mohamad Reza ;
Mortaz, Esmaeil ;
Tabarsi, Payam ;
Jamaati, Hamidreza ;
Maghsoomi, Zohreh ;
Khosravi, Adnan ;
Garssen, Johan ;
Masjedi, Mohamad Reza ;
Velayati, Ali Akbar ;
Folkerts, Gert ;
Barnes, Peter J. ;
Adcock, Ian M. .
JOURNAL OF INFLAMMATION-LONDON, 2014, 11
[26]   Plasma levels of soluble receptor for advanced glycation end products in patients with acute respiratory distress syndrome [J].
Gu, Weili ;
Xu, Zhihua ;
Qi, Feng ;
Sang, Zhihui ;
Wang, Chunhua ;
Li, Feng .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (12) :5558-5562
[27]   High levels of circulating leukocyte microparticles are associated with better outcome in acute respiratory distress syndrome [J].
Guervilly, Christophe ;
Lacroix, Romaric ;
Forel, Jean-Marie ;
Roch, Antoine ;
Camoin-Jau, Laurence ;
Papazian, Laurent ;
Dignat-George, Francoise .
CRITICAL CARE, 2011, 15 (01)
[28]   Acute Respiratory Distress Syndrome and Fluid Management: Finding the Perfect Balance [J].
Zernini, Irene Sbaraini ;
Nocera, Domenico ;
D'Albo, Rosanna ;
Tonetti, Tommaso .
JOURNAL OF CLINICAL MEDICINE, 2025, 14 (06)
[29]   Surfactant protein-A levels in patients with acute respiratory distress syndrome [J].
Balamugesh, T ;
Kaur, S ;
Majumdar, S ;
Behera, D .
INDIAN JOURNAL OF MEDICAL RESEARCH, 2003, 117 :129-133
[30]   High-Frequency Oscillation for Acute Respiratory Distress Syndrome [J].
Young, Duncan ;
Lamb, Sarah E. ;
Shah, Sanjoy ;
MacKenzie, Iain ;
Tunnicliffe, William ;
Lall, Ranjit ;
Rowan, Kathy ;
Cuthbertson, Brian H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (09) :806-813
12345